TY - JOUR
T1 - Venous Thromboembolism Prophylaxis in Total Knee Arthroplasty and Total Hip Arthroplasty
AU - Locke, Charles
AU - Moreland, Christopher
PY - 2013/1/1
Y1 - 2013/1/1
N2 - Prevention of venous thromboembolism (VTE) in the surgical patient is a paramount medical issue. VTE is superseded only by infection as the most common medical complication causing increased length of stay for surgical patients. All total knee arthroplasty (TKA) and total hip arthroplasty (THA) patients should be assessed for an appropriate VTE prophylaxis strategy. Preferred pharmacoprophylaxis options currently include warfarin, low molecular weight heparin, fondaparinux, and rivaroxiban. Mechanical prophylaxis is recommended in all patients who are undergoing THA or TKA and are at increased risk of bleeding whereby chemoprophylaxis is contraindicated.
AB - Prevention of venous thromboembolism (VTE) in the surgical patient is a paramount medical issue. VTE is superseded only by infection as the most common medical complication causing increased length of stay for surgical patients. All total knee arthroplasty (TKA) and total hip arthroplasty (THA) patients should be assessed for an appropriate VTE prophylaxis strategy. Preferred pharmacoprophylaxis options currently include warfarin, low molecular weight heparin, fondaparinux, and rivaroxiban. Mechanical prophylaxis is recommended in all patients who are undergoing THA or TKA and are at increased risk of bleeding whereby chemoprophylaxis is contraindicated.
KW - Pharmacoprophylaxis
KW - Total hip arthroplasty
KW - Total knee arthroplasty
KW - Venous thromboembolism
UR - http://www.scopus.com/inward/record.url?scp=84870486097&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84870486097&partnerID=8YFLogxK
U2 - 10.1016/j.ehmc.2012.08.002
DO - 10.1016/j.ehmc.2012.08.002
M3 - Review article
AN - SCOPUS:84870486097
VL - 2
SP - e91-e102
JO - Hospital Medicine Clinics
JF - Hospital Medicine Clinics
SN - 2211-5943
IS - 1
ER -